Volume | 6,440,174 |
|
|||||
News | (11) | ||||||
Day High | 129.3599 | Low High |
|||||
Day Low | 126.88 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Merck and Co Inc | MRK | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
127.76 | 126.88 | 129.3599 | 128.71 | 128.42 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
82,079 | 6,440,174 | $ 128.39 | $ 826,826,634 | - | 99.14 - 133.10 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:35:04 | 1 | $ 126.50 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
325.98B | 2.53B | - | 60.12B | 365M | 0.14 | 893.20 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Merck News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 129.27 | 129.3599 | 122.70 | 125.85 | 11,523,846 | -0.51 | -0.39% |
1 Month | 127.01 | 132.79 | 122.70 | 128.62 | 7,809,423 | 1.75 | 1.38% |
3 Months | 123.03 | 133.10 | 119.41 | 126.80 | 8,423,799 | 5.73 | 4.66% |
6 Months | 103.78 | 133.10 | 102.65 | 121.72 | 8,293,639 | 24.98 | 24.07% |
1 Year | 112.75 | 133.10 | 99.14 | 114.59 | 7,814,256 | 16.01 | 14.20% |
3 Years | 74.20 | 133.10 | 70.89 | 95.16 | 9,806,804 | 54.56 | 73.53% |
5 Years | 80.75 | 133.10 | 65.25 | 89.13 | 9,940,984 | 48.01 | 59.46% |
Merck Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |